Specific to MMR, the demonstration that this vaccine was also able to induce trained immunity could lead to the hypothesis that it may have beneficial heterologous effects in groups of individuals such as the elderly and immunocompromised who have increased susceptibility to infections. The gene discussed is MRC1; the disease is infection.